GM-XANTHO

Exhibitor: XANTHO BIOTECHNOLOGY CO., LTD.

Booth No: M434

Characteristic

Xantho Biotech. is founded in 2014, the company is a startup at the DCB Nangang Incubation Center and is dedicated to developing botanical new drugs with low side effects suitable for long-term use, focusing on inflammatory skin diseases caused by immune dysregulation.
The company’s main product is a proprietary botanical drug topical cream called GM-XANTHO developed in-house, using mangosteen extract as the active pharmaceutical ingredient. It is intended for the treatment of recurrent inflammatory skin diseases such as atopic dermatitis and psoriasis. The company has completed Phase 2a human clinical trials and is currently planning Phase 2b clinical trials in the United States and Europe.